# TASK VRTX-0286: CI/Build verification and documentation update

**Sprint:** SPRINT-0054
**Phase:** CI/Build Verification & Documentation Update
**Duration estimate:** 35 minutes
**Depends on:** VRTX-0285 (Implement and test variant endpoint 85511011)

---

## Overview

Verify the new endpoint is included in the production build, all CI checks pass, and update root documentation to reflect the new variant. This task ensures the implementation is production-ready and documented.

## File/Module Ownership Map

**Files to create:** None (this is verification + documentation)

**Files to modify (documentation only):**
- `PRODUCT.md` — Add variant 85511011 to health check inventory and add changelog entry
- `ARCHITECTURE.md` — Add variant 85511011 to health check inventory and add changelog entry
- `DESIGN.md` — Add changelog entry (no design changes)
- `AGENT.md` — Add changelog entry (no agent protocol changes)

**No code files modified in this task** (implementation is complete in VRTX-0283)

**CI/Build files (verified, not modified):**
- `.eslintrc.js` / ESLint config — verify no new warnings
- `tsconfig.json` — verify type checking passes
- `vitest.config.ts` — verify test discovery works
- `package.json` / build scripts — verify build succeeds

## Background & Context

All implementation is complete from VRTX-0283 (route.ts and route.test.ts are committed). This task verifies the build pipeline and updates documentation.

**CI pipeline to verify:**
1. **Type checking** — `npm run typecheck` passes with zero errors
2. **Linting** — `npm run lint` passes with --max-warnings 0
3. **Tests** — `npm run test` passes, including new 14 tests
4. **Build** — `npm run build` succeeds, endpoint is bundled
5. **No regressions** — all existing health check endpoints still work

**Documentation to update:**
- PRODUCT.md: Variant endpoints inventory (mentioned in "Operations & monitoring" section)
- ARCHITECTURE.md: Health check endpoints section + inventory in section 5
- DESIGN.md: Changelog entry (no design changes)
- AGENT.md: Changelog entry (no agent protocol changes)

## Implementation Details

### Phase 3: CI/Build Verification

**Step 1: Local verification (engineer runs before pushing)**
```bash
npm run typecheck          # TypeScript — zero errors
npm run lint              # ESLint — zero warnings
npm run test              # Vitest — all tests pass (including new 14 tests)
npm run build             # Next.js build — succeeds, endpoint bundled
```

**Expected output:**
- Typecheck: `tsc --noEmit` completes with exit code 0
- Lint: `eslint . --max-warnings 0` passes
- Test: All test suites pass, including `route.test.ts` with 14 tests
- Build: Next.js build completes, `dist/` or `.next/` contains new route

**Verification criteria:**
- No new TypeScript errors in the codebase
- No new ESLint warnings in route.ts or route.test.ts
- All 14 tests for `GET /api/healthz-smoke-85511011` pass
- Production build succeeds and includes the new endpoint
- No regressions in existing health check endpoints (verify `/api/health`, `/api/healthz-smoke`, other variants still work)

**Step 2: Regression testing**
Verify no existing endpoints broke:
- `/api/health` — still returns status/timestamp
- `/api/healthz-smoke` — still returns `{ data: { ok: true }, error: null }`
- `/api/healthz-smoke-110428092` — still returns `{ ok: true, variant: "110428092" }`
- `/api/healthz-smoke-28611693` — still returns `{ ok: true, variant: "28611693" }`

### Phase 4: Documentation Update

**Step 1: Update PRODUCT.md**
- In section "8. Operations & monitoring", update the "Variant smoke test endpoints" paragraph to include `85511011` in the inventory of current variants
- Add dated changelog entry (2026-07-11 — SPRINT-0054) describing the new endpoint
- Changelog format: describe product value (operations can verify variant 85511011 is deployed), capability added (variant-specific health check), and pattern continued

**Step 2: Update ARCHITECTURE.md**
- In section "5. Health check endpoints", update the inventory of `/api/healthz-smoke-{variant}` to list `85511011` (SPRINT-0054) first
- Add detailed changelog entry (2026-07-11 — SPRINT-0054) with implementation details
- Include response format, dependencies, and test suite summary

**Step 3: Update DESIGN.md**
- Add changelog entry (2026-07-11 — SPRINT-0054) stating "no design changes" (consistent with previous variant sprints)
- Follows the established pattern for non-design sprints

**Step 4: Update AGENT.md**
- Add changelog entry (2026-07-11 — SPRINT-0054) stating "no agent protocol changes" (consistent with previous variant sprints)
- Follows the established pattern for non-agent-change sprints

**Documentation style:**
- All entries dated 2026-07-11 (today)
- Format mirrors previous variant sprints (SPRINT-0053, SPRINT-0052, SPRINT-0051)
- Emphasize product value and operations team benefit
- Include implementation details (route file, hardcoded variant, response format, test count)
- Changelog is the primary source of record for sprint changes

## Acceptance Criteria (Definition of Done)

✅ **CI/Build verification complete:**
- `npm run typecheck` passes locally with zero errors
- `npm run lint` passes locally with zero warnings (--max-warnings 0)
- `npm run test` passes locally, including all 14 tests for new endpoint
- `npm run build` succeeds, production build is complete
- No regressions in existing health check endpoints

✅ **Documentation complete:**
- PRODUCT.md: Variant 85511011 mentioned in health check inventory
- PRODUCT.md: Dated changelog entry for SPRINT-0054
- ARCHITECTURE.md: Variant 85511011 listed in health check endpoints inventory
- ARCHITECTURE.md: Dated changelog entry for SPRINT-0054
- DESIGN.md: Dated changelog entry stating no design changes
- AGENT.md: Dated changelog entry stating no agent protocol changes

✅ **Root documents verified:**
- All docs are holistic, current target-state documents (not deltas)
- Changelog entries follow established format from previous sprints
- No typos or formatting inconsistencies
- Links and cross-references are accurate

✅ **Git workflow:**
- All documentation changes committed on ticket branch with clear message
- Commit includes PRODUCT.md, ARCHITECTURE.md, DESIGN.md, AGENT.md
- Can be squashed with implementation commit(s) from VRTX-0283 or left separate (both acceptable)

## Success Metrics

- All CI checks pass locally
- Production build succeeds without warnings
- No performance impact (endpoint response time remains < 100ms)
- Documentation is complete and consistent
- Zero regressions in existing functionality

## Related Documentation

- **SPRINT-PLAN.md** — Phase 3 (CI/Build Verification) and Phase 4 (Documentation Update)
- **PRODUCT.md, ARCHITECTURE.md, DESIGN.md, AGENT.md** — Current versions to be updated
- **Previous variant sprints** — SPRINT-0053, SPRINT-0052, SPRINT-0051 (changelog format reference)

## Notes

- Documentation updates are low-risk; they reflect what was already implemented in VRTX-0283
- No code changes in this task (all code is from VRTX-0283)
- Documentation is the contract for future variants; must be kept accurate and consistent
- Changelog entries are the primary source of record for what changed in each sprint
